25 September 2022
Cardiovascular disease is a growing burden and one of the leading causes of death in Bangladesh. In most cases, the exact cause of CVD is not known, but a combination of factors can increase the risk of getting heart disease.
Considering the risk factors associated with heart disease, DBL Pharma has celebrated “World Heart Day 2022” by arranging a scientific seminar on “Residual Risk in management of lipid to reduce cardiovascular diseases” at Hotel Radisson Blu on 23 September 2022.
The seminar is chaired by eminent Professor (Dr.) AKM Mohibullah (President, Bangladesh Cardiac Society), and the key topic was presented by renowned Cardiologist Prof. (Dr.) Abdullah Al Shafi Majumder (Secretary General, Bangladesh Cardiac Society) in the presence of distinguished physicians from different dimensions of Cardiology, Medicine, Diabetology, Endocrinology, Nephrology etc.
Prof. Dr. Shamim Ahmed, Prof. Dr. Syed Ali Ahsan, Prof. Dr. Khaled Mohsin, Prof. Dr. Mir Jamal Uddin, Prof. Dr. Abdul Wadud Chowdhury, Prof. Dr. Md. Khalequzzaman, Prof. Dr. A K M Manzurul Alam, Prof. Dr. Indrajit Prasad were present as expert panelist.
Prof. (Dr.) A A Shafi Majumder explained all the less addressed residual risk factors for cardiovascular diseases & its management and the expert panelists discussed it, which will definitely play an important role in reducing the burden of cardiovascular diseases in Bangladesh. As a scientific partner, DBL Pharma will continue this type of program and is passionate to use its heart to care every heart of the people.
DBL Pharmaceuticals Ltd. hosted its 3rd Annual Business Conference on January 11, 2025, at Cox’s Bazar. The event brought together the company’s sales & marketing team along with key stakeholders to discuss its mission of providing high-quality and innovative medicines for better healthcare. The Board of Directors including Chairman Mr. Abdul Wahed, Managing Director Mr.… Continue reading DBL Pharma celebrates 3rd Annual Business Conference with Vision to Victory
DBL pharma recently unveiled Seretrol-F Sykonahaler, which is a technologically advanced Multi-Dose Dry Powder Inhaler. This device will ensure precise treatment for the management of Asthma & COPD and overcome the limitation of the conventional devices. The grand launching event is endorsed by Bangladesh Lung Foundation (BLF) and held at Sheraton Banani, Dhaka on 05… Continue reading DBL pharma launches Seretrol-F Sykonahaler
DBL Pharmaceuticals Limited Celebrates International Mother Language Day with Free Medical Camp and Medicine Distribution
In celebration of International Mother Language Day, DBL Pharmaceuticals Limited successfully organized a Free Medical Camp and Medicine Distribution on February 21, 2025, at 15 different locations across the country. The event aimed to provide essential healthcare services to diabetic patients, offering free diabetes testing and blood pressure check-ups. Specialist doctors and healthcare assistants were… Continue reading DBL Pharmaceuticals Limited Celebrates International Mother Language Day with Free Medical Camp and Medicine Distribution